Guidance
← 실적 발표
01
02
03
04 05 06
톤
A1 A2 A3
BRO
FY2025 Q4
개선
Brown & Brown, Inc. 실적 발표
Buzzberg 분석
Cautiously optimistic about 2026 organic growth
Brown & Brown reported a strong Q4 with significant total revenue growth driven by M&A, but organic growth was negative due to a tough comparison from prior-year flood revenue. Management discusses the impact of falling E&S property rates, rising employee benefits costs, and the competitive threat from a startup broker poaching talent. Q4 total revenues grew 35.7% to $1.6B, but organic revenue decreased 2.8% due to prior-year flood claims processing revenue.
Buzzberg 분석 Cautiously optimistic about 2026 organic growth Brown & Brown reported a strong Q4 with significant total revenue growth driven by M&A, but organic growth was negative due to a tough comparison from prior-year flood revenue. Management discusses the impact of falling E&S property rates, rising employee benefits costs, and the competitive threat from a startup broker poaching talent. Q4 total revenues grew 35.7% to $1.6B, but organic revenue decreased 2.8% due to prior-year flood claims processing revenue. 전체 분석 보기분석 접기
Brown & Brown reported a strong Q4 with significant total revenue growth driven by M&A, but organic growth was negative due to a tough comparison from prior-year flood revenue. Management discusses the impact of falling E&S property rates, rising employee benefits costs, and the competitive threat from a startup broker poaching talent. Q4 total revenues grew 35.7% to $1.6B, but organic revenue decreased 2.8% due to prior-year flood claims processing revenue.
- The company completed a record year for M&A, adding ~$1.8B of annual revenue, led by the acquisition of AssuredPartners.
- Management notes increased competition from a startup broker (implied to be Howden) that poached 275 employees and took $23M in known annual revenues.
- Property catastrophe reinsurance rates are declining 15-30%, and some binding authority business is moving back to the admitted market.
매출$1.669B보고값
주당순이익(EPS)$0.93보고값
매출총이익률83.82%보고값
영업이익률25.7%보고값
근거 있는 핵심 내용 6개
지금 중요한 점
이번 발표에서 가장 의미 있는 변화를 정리했습니다.
Margins
Raising long-term margin target range to 32-37%
Competition
Startup broker poaches 275, taking $23M revenue
핵심 내용 3개 더 보기
Pricing
Expect continued moderation in casualty rate increases
Pricing
Expect cap property rates to decline modestly
M&A
Integration of AssuredPartners on track, synergies expected
보고 기간
보고 실적
| 지표 | 보고값 | 변화 |
|---|---|---|
| 매출 | $1.669B | 보고값 |
| 주당순이익(EPS) | $0.93 | 보고값 |
| 매출총이익률 | 83.82% | 보고값 |
| 영업이익률 | 25.7% | 보고값 |
| 잉여현금흐름 | $0.424B | 보고값 |
| 자본지출 | $0.02B | 보고값 |
향후 전망
향후 가이던스
| 지표 | 기간 | 범위 | 중간값 | 상태 |
|---|---|---|---|---|
| 영업이익률 | FY2026 | 32%–37% | 34.5% | 상향 |
AI, 자본지출 및 수요 분석
경영진 분석
Measured
Management strikes a balanced, confident tone, acknowledging headwinds like the poaching of teammates and market softening while emphasizing strong cash flow and disciplined execution.
아래에 언급된 기업 3개 모두 표시
기업발표 이후 수익률
공급망
공급망
Powell Brown
Employee benefits pricing for medical and pharmacy costs is rising sharply (medical +7-9%, pharmacy +10%), indicating persistent healthcare cost inflation. — Sustained high medical/pharmacy costs suggests robust pricing power for major health insurers and pharmacy benefit managers (PBMs), potentially supporting their revenue growth.
근거
“Pricing for employee benefits increased slightly as compared to prior quarters, with medical costs up 7% to 9% and pharmacy costs up over 10%.”
공급망
Andy
Business is moving from the E&S market to the admitted market due to competitive pricing, but the long-term trend still favors more insured assets moving into the E&S space. — Despite cyclical shifts, secular demand for flexible E&S capacity remains strong, benefiting carriers like Chubb that underwrite surplus lines.
근거
“we continue to believe that there's going to be more insured assets, though, moving into the ENS space versus moving back into the admitted.”
외부 신호
공급망 알파 · 3발표 이후 수익률
The decrease in excess & surplus (E&S) property rates is driving some binding authority business to move back into the admitted market, a cyclical shift that could pressure specialty distribution organic growth.
근거
“we saw some binding authority business move back into the admitted market.”
Employee benefits pricing for medical and pharmacy costs is rising sharply (medical +7-9%, pharmacy +10%), indicating persistent healthcare cost inflation.
Business is moving from the E&S market to the admitted market due to competitive pricing, but the long-term trend still favors more insured assets moving into the E&S space.
방법론 및 범위
경영진 발언만 분석합니다. 검증된 기업 언급 3개를 모두 표시하며, 보고 실적과 향후 가이던스를 분리합니다. 공개 근거는 화자가 표시된 짧은 인용문 8개로 제한됩니다. AI 분석은 불완전하거나 틀릴 수 있으므로 중요한 주장은 원문에서 확인하세요.